Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth.

MLA

Moscicki, Anna-Barbara, et al. “Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-Infected and Exposed, Uninfected Youth.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 69, no. 7, Sept. 2019, pp. 1183–91. EBSCOhost, https://doi.org/10.1093/cid/ciy1040.

APA

Moscicki, A.-B., Karalius, B., Tassiopoulos, K., Yao, T.-J., Jacobson, D. L., Patel, K., Purswani, M., & Seage, G. R. (2019). Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-infected and Exposed, Uninfected Youth. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 69(7), 1183–1191. https://doi.org/10.1093/cid/ciy1040

Chicago

Moscicki, Anna-Barbara, Brad Karalius, Katherine Tassiopoulos, Tzy-Jyun Yao, Denise L Jacobson, Kunjal Patel, Murli Purswani, and George R Seage. 2019. “Human Papillomavirus Antibody Levels and Quadrivalent Vaccine Clinical Effectiveness in Perinatally Human Immunodeficiency Virus-Infected and Exposed, Uninfected Youth.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 69 (7): 1183–91. doi:10.1093/cid/ciy1040.